Screener
Eligibility screening
Lu-177 Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application
4 US sites in CA, MD, PA
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.